Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Express Scripts
Johnson and Johnson
US Department of Justice

Generated: November 21, 2017

DrugPatentWatch Database Preview

BLOXIVERZ Drug Profile

« Back to Dashboard

What is the patent landscape for Bloxiverz, and what generic Bloxiverz alternatives are available?

Bloxiverz is a drug marketed by Eclat Pharms Llc and is included in one NDA.

The generic ingredient in BLOXIVERZ is neostigmine methylsulfate. There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the neostigmine methylsulfate profile page.

Pharmacology for BLOXIVERZ

Medical Subject Heading (MeSH) Categories for BLOXIVERZ

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eclat Pharms Llc
neostigmine methylsulfate
SOLUTION;INTRAVENOUS204078-001May 31, 2013APRXYesYes► Subscribe► Subscribe► Subscribe
Eclat Pharms Llc
neostigmine methylsulfate
SOLUTION;INTRAVENOUS204078-002May 31, 2013APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Cantor Fitzgerald
Daiichi Sankyo
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus